{
    "success": true,
    "data": {
        "leverage": true,
        "derivates": true,
        "swaps": true,
        "inverse": true,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Leverage",
            "Inverse",
            "Synthetic Replication",
            "Compounding Effect",
            "Derivative Use Integral to Strategy",
            "Complex Index",
            "Targets Sophisticated Investors",
            "Explicit Comprehension Alert"
        ],
        "classification": "complex",
        "supporting_data": "The product is identified as 'ETP Securities', not a UCITS ETF, thus the MiFID II UCITS presumption of non-complexity does not apply. Its core objective is to provide -3 times the daily performance of the underlying UBS Group AG equity, which inherently involves significant leverage and an inverse strategy. This performance is achieved through synthetic replication, as indicated by the description of 'Collateral Assets' held in a 'Margin Account' and 'securities loans' funding payment obligations, rather than direct physical holdings of the underlying equity. This confirms that derivatives are integral to its investment objective. The KID explicitly states, 'You are about to purchase a product that is not simple and may be difficult to understand,' and targets 'sophisticated investors' who can 'understand the risk of compounded returns' and have a 'very short investment horizon.' The 'Compounding Effect' itself is a complex phenomenon that can significantly alter returns over longer holding periods, which is difficult for an average retail investor to fully grasp. The product's risk indicator is 7 out of 7, the highest risk class. Furthermore, under ESMA guidance (CESR/09-295, ANNEX I, Section 4), financial instruments like Exchange Traded Commodities structured as contracts for difference (which this ETP is analogous to in its derivative-like payoff) are 'ALWAYS COMPLEX UNDER ART.38 OF MiFID LEVEL 2 DIRECTIVE' as they fall under Article 4(1)(18)(c) of MiFID Level 1. All these elements definitively classify the product as complex."
    }
}